NGRC Projected Dividend Yield
National Graphite Corp ( OTCBB : NGRC )National Graphite through its subsidiary, Biotech Development Corp. (BDC) collaborates with clinical stage companies that develops new biological entities or new therapeutically platforms in the treatment for a range of diseases, rare diseases and diseases with unmet needs. As of May 31 2015, Co. collaborated with Proteo Inc. Proteo Inc. is a clinical stage drug development company and is developing and market biopharmaceuticals and other biotech products. Proteo focuses on the clinical development of ELAFIN for treatment of postoperative inflammatory complications in the surgical therapy of esophagus carcinoma. 20 YEAR PERFORMANCE RESULTS |
NGRC Dividend History Detail NGRC Dividend News NGRC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |